Joint analysis of candidate genes related to Alzheimer's disease in a Spanish population

Psychiatric Genetics

Volumn 13, Issue 2, 2003, Pages 85-90

  Clarimón, Jordi ^a   Bertranpetit, Jaume ^a   Calafell, Francesc ^a   Boada, Mercè ^b   Tàrraga, Lluís ^b   Comas, David ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b IC Neurociències Aplicades ^*  (Spain)

Author keywords

Alpha 1 antichymotripsin; Alpha 2 macroglobulin; Alzheimer's dementia; Apolipoprotein E; Bleomycin hydrolase; Heat shock protein 70 2; Interleukin 1 alpha; Polymorphism

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E; BLEOMYCIN HYDROLASE; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SPAIN; STRATIFICATION;

ALZHEIMER DISEASE; APOLIPOPROTEINS E; BASE SEQUENCE; DNA PRIMERS; GENETIC MARKERS; HUMANS; INTERLEUKIN-1; LINKAGE DISEQUILIBRIUM; MICROSATELLITE REPEATS; POLYMORPHISM, GENETIC; REFERENCE VALUES; SPAIN;

EID: 0038686941     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200306000-00005     Document Type: Article

References (42)

1. Bertranpetit J, Cavalli-Sforza LL (1991). A genetic reconstruction of the history of the population of the Iberian Peninsula. Ann Hum Genet 55:51-67.
2. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RC, et al. (1998). Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 19:357-360.
3. Bullido MJ, Artiga MJ, Recuero M, Sastre I, Garcia MA, Aldudo J, et al. (1998). A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat Genet 18:69-71.
4. Calafell F, Bertranpetit J (1994). Principal component analysis of gene frequencies and the origin of basques. Am J Phys Anthropol 93:201-215.
5. Casadei VM, Ferri C, Veglia F, Gavazzi A, Salani G, Cattaneo M, et al. (1999). APOE-491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease. Neurology 53:1888-1889.
6. Czech C, Monning V, Tienari PJ, Hartmann T, Masters C, Beyreuther K, Forstl H (1993). Apolipoprotein E-epsilon 4 allele and Alzheimer's disease. Lancet 342:1309. Letter.
7. Daw EW, Payami H, Nemens E, Nochlin D, Bird TD, Schellenberg GD, et al. (2000). The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66:196-204.
8. Dodel RC, Du Y, Bales KR, Gao F, Eastwood B, Glazier B, et al. (2000). Alpha2 macroglobulin and the risk of Alzheimer's disease. Neurology 54:438-442.
9. Dow DJ, Lindsey N, Cairns NJ, Brayne C, Robinson D, Huppert FA, et al. (1999). Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat Genet 22:16-17.
10. Dressel R, Gunther EA (1994). Pentanucleotide tandem duplication polymorphism in the 3′ untranslated region of the HLA-linked heat-shock protein 70-2 (HSP70-2) gene. Hum Genet 94:585-586.
11. Du Y, Dodel RC, Eastwood BJ, Bales KR, Gao F, Lohmuller F, et al. (2000). Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology 55:480-483.
12. Farrer LA, Abraham CR, Haines JL, Rogaeva EA, Song Y, McGraw WT, et al. (1998). Association between bleomycin hydrolase and Alzheimer's disease in caucasian. Ann Neurol 44:808-811.
13. Fidani L, Goulas A, Mirtsou V, Petersen RC, Tangalos E, Crook R, Hardy J (2002). Interleukin-1A polymorphism is not associated with late onset Alzheimer's disease. Neurosci Lett 323:81-83.
14. Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, et al. (2000). Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol 47:361-365.
15. Helisalmi S, Hiltunen M, Valonen P, Mannermaa A, Koivisto AM, Lehtovirta M, et al. (1999). Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals. J Neurol 246:821-824.
16. Hixson JE, Vernier DT (1990). Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 31:545-548.
17. Janka Z, Juhasz A, Rimanoczy A, Boda K, Marki-Zay J, Palotas M, et al. (2002). Alpha2-Macroglobulin exon 24 (Val-1000-IIe) polymorphism is not associated with late-onset sporadic Alzheimer's dementia in the Hungarian population. Psychiatr Genet 12:49-54.
18. Ki CS, Na DL, Kim HJ, Kim JW (2001). Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease. Neurosci Lett 302:69-72.
19. Kovacs T, Cairns NJ, Lantos PL (1999). Alpha-2-macroglobulin intronic polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease. Neurosci Lett 273:61-83.
20. Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, et al. (1998). Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet 7:1511-1516.
21. Liao A, Nitsch RM, Greenberg SM, Finckh U, Blacker D, Albert M, et al. (1998). Genetic association of an alpha2-macroglobulin (Val1000IIe) polymorphism and Alzheimer's disease. Hum Mol Genet 7:1953-1956.
22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944.
23. Minster RL, DeKosky ST, Ganguli M, Belle S, Kamboh MI (2000). Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease. Ann Neurol 48:817-819.
24. Montoya SE, Aston CE, DeKosky ST, Kamboh MI, Lazo JS, Ferrell RE (1998). Bleomycin hydrolase is associated with risk of sporadic Alzheimer's disease. Nat Genet 18:211-212.
25. Morgan K, Morgan L, Carpenter K, Lowe J, Lam L, Cave S, et al. (1997). Microsatellite polymorphism of the α1-antichymotrypsin gene locus associatied with sporadic Alzheimer's disease. Hum Genet 99:27-31.
26. Myllykangas L, Polvikoski T, Sulkava R, Verkkoniemi A, Crook R, Tienari PJ, et al. (1999). Genetic association of alpha2-macroglobulin with Alzheimer's disease in a Finnish elderly population. Ann Neurol 46:382-390.
27. Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, et al. (2000). Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 47:365-368.
28. Papassotiropoulos A, Bagli M, Jessen F, Frahnert C, Rao ML, Maier W, Heun R (2000). Confirmation of the association between bleomycin hydrolase genotype and Alzheimer's disease. Mol Psychiatry 5:213-215.
29. Pericak-Vance MA, Haines JL (1995). Genetic susceptibility to Alzheimer disease. Trends Genet 11:504-508.
30. Poller W, Faber JP, Olek K (1991). Sequence polymorphism in the human alpha-2-macroglobulin (A2M) gene. Nucleic Acids Res 19:198. Letter.
31. Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, Nagga K, et al. (2001). Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 9:437-944.
32. Rebeck GW (2000). Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease. Neurosci Lett 293:75-77.
33. Rudrasingham V, Wavrant-De Vrièze F, Lambert JC, Chakraverty S, Kehoe P, Crook R, et al. (1999). Alpha-2 macroglobulin gene and Alzheimer disease. Nat Genet 22:17-19.
34. Schneider S, Kueffer JM, Roessli D, Excoffier L (2000). Arlequin version 2000: a software environment for the analysis of population genetics data. Geneva: Genetics Biometry Laboratory, University of Geneva.
35. Slatkin M, Excoffier L (1996). Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity 76 (Part 4):377-383.
36. Song VQ, Rogaeva E, Premkumar S, Brindle N, Kawarai T, Orlacchio A, et al. (1998). Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE. Neurosci Lett 250:189-192.
37. Tsai MS, Tangalos EG, Petersen RC, Smith GE, Schaid DJ, Kokmen E, et al. (1994). Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 54:643-649.
38. Wakutani Y, Urakami K, Shimomura T, Takahashi K (1995). Heat shock protein 70 mRNA levels in mononuclear blood cells from patients with dementia of the Alzheimer type. Dementia 6:301-305.
39. Warwick DE, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, Wiisman EM (2000). The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66:196-204.
40. Warrant-De Vrièze F, Rudrasingham V, Lambert JC, Chakraverty S, Kehoe P, Crook R, et al. (1999a). No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci Lett 262:137-139.
41. Wavrant-De Vrièze F, Crook R, Holmans P, Kehoe P, Owen MJ, Williams J, et al. (1999b). Genetic variability at the amyloid-β precursor protein locus may contribute to the risk of late-onset Alzheimer's disease. Neurosci Lett 269:67-70.
42. Zurutuza L, Verpillat P, Raux G, Hannequin D, Puel M, Belliard S, et al. (2000). APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. Eur J Hum Genet 8:713-716.